Breaking News Instant updates and real-time market news.

MRUS

Merus

$28.50

-1.48 (-4.94%)

, INCY

Incyte

$148.52

0.56 (0.38%)

05:36
03/21/17
03/21
05:36
03/21/17
05:36

Merus downgraded to Neutral from Buy at Citi

Citi analyst Yigal Nochomovitz downgraded Merus (MRUS) to Neutral saying that while the company's fundamentals continue to look "solid," the stock is fairy valued after rallying 50% following the Incyte (INCY) deal. The analyst raised his price target for the shares to $31 from $26.

MRUS

Merus

$28.50

-1.48 (-4.94%)

INCY

Incyte

$148.52

0.56 (0.38%)

  • 01

    Apr

  • 02

    Apr

  • 19

    Apr

MRUS Merus
$28.50

-1.48 (-4.94%)

12/21/16
JEFF
12/21/16
NO CHANGE
Target $29
JEFF
Buy
Jefferies ups Merus target to $29 after Incyte collaboration
Jefferies analyst Brian Abrahams views today's announced bispecific collaboration between Merus (MRUS) and Incyte (INCY) as a win for Merus. The deal provides "capital flexibility and strong validation" of the company's platform, while enabling maintenance of full rights to its clinical programs, Abrahams tells investors in a research note. He raised his price target for Merus shares to $29 from $21 and keeps a Buy rating on the name. The stock is up 45%, or $6.30, to $20.45 in midday trading.
12/22/16
SBSH
12/22/16
UPGRADE
Target $26
SBSH
Buy
Merus upgraded to Buy from Neutral at Citi
Citi analyst Yigal Nochomovitz upgraded Merus (MRUS) to Buy saying the Incyte (INCY) collaboration deal has "very favorable" terms. The deal with a "high-profile" company coupled with a $200M upfront payment "should meaningfully increase Street visibility," Nochomovitz tells investors in a research note. He raised his price target for Merus shares to $26 from $19. The stock closed yesterday up 43% to $20.22.
12/22/16
12/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Micron (MU) was upgraded to Buy from Hold at Cross Research, to Buy from Underperform at Needham, and to Buy from Hold at Summit Redstone. 2. Sunoco (SUN) upgraded to Outperform from Market Perform at FBR Capital with analyst Robert Balsamo saying the credit facility amendments announced reduce the need for a distribution cut. The analyst has a $32 price target for the shares. 3. National Instruments (NATI) upgraded to Outperform from Neutral at Baird with analyst Richard Eastman saying he sees the potential for accelerating revenue growth over the next few years combined with more determined focus to deliver operating leverage. 4. Merus (MRUS) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying the Incyte (INCY) collaboration deal has "very favorable" terms. 5. Sucampo (SCMP) upgraded to Buy from Neutral at Mizuho with the firm citing the sell-off in shares post the $260M convertible raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/28/16
JEFF
12/28/16
NO CHANGE
Target $29
JEFF
Buy
Merus still undervalued despite yesterday's rally, says Jefferies
Jefferies analyst Brian Abrahams says he continues to believe shares of Merus (MRUS) are undervalued. The stock rose 5% yesterday to $20.91. Seattle Genetics' (SGEN) toxicity roadblock highlights the unmet need for new mechanisms, but also the challenges in acute myeloid leukemia, Abrahams tells investors in a research note. Merus' MCLA-117 has looked safe thus far and has a differentiated profile, the analyst contends. He keeps a Buy rating on the shares with a $29 price target.
INCY Incyte
$148.52

0.56 (0.38%)

01/31/17
RHCO
01/31/17
NO CHANGE
RHCO
Incyte price target raised to $140 from $115 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Incyte (INCY), citing "increased pipeline & technology value" as data releases and PDUFA dates approach. Additionally, the analyst is upbeat on the company's global collaboration deal with Calithera (CALA), saying that the deal expands Incyte's "reach into the (immuno-oncology) space." The analyst reiterates a Buy rating on Incyte.
03/01/17
NOMU
03/01/17
INITIATION
Target $148
NOMU
Buy
Incyte initiated with a Buy at Nomura
Nomura initiated Incyte with a Buy and a $148 price target.
03/08/17
UBSW
03/08/17
INITIATION
Target $140
UBSW
Neutral
Incyte initiated with a Neutral at UBS
UBS analyst Carter Gould initiated Incyte with a Neutral and a $140 price target.
03/13/17
FBCO
03/13/17
NO CHANGE
Target $174
FBCO
Outperform
Incyte price target raised to $174 from $136 at Credit Suisse
Credit Suisse analyst Kennen MacKay raised his price target for Incyte (INCY) to $174 upon shifting to an M&A discounted cash flow net present value methodology. Incyte rallied late in the day on Friday amid speculation of a takeover by Gilead Sciences (GILD). Incyte could provide an attractive entry into immuno-oncology for an acquirer, MacKay tells investors in a research note. The company's epacadostat could be a "scarce immuno-oncology backbone blockbuster," the analyst contends. He anticipates "significant interest" in Incyte for this reason. MacKay keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

REGN

Regeneron

$369.14

-1.84 (-0.50%)

, GSK

GlaxoSmithKline

$42.28

-0.04 (-0.09%)

20:06
03/22/17
03/22
20:06
03/22/17
20:06
Hot Stocks
Regeneron announces 'major' gene sequencing effort with Glaxo, U.K. Biobank »

Regeneron (REGN)…

REGN

Regeneron

$369.14

-1.84 (-0.50%)

GSK

GlaxoSmithKline

$42.28

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 29

    Mar

  • 06

    Jun

ALK

Alaska Air

$92.92

0.81 (0.88%)

19:51
03/22/17
03/22
19:51
03/22/17
19:51
Hot Stocks
Alaska Air outlines post-merger 'vision,' says enhancing several brand elements »

Alaska Airlines and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

FB

Facebook

$139.59

1.08 (0.78%)

19:35
03/22/17
03/22
19:35
03/22/17
19:35
Hot Stocks
Instagram says monthly active advertisers tops 1M »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

FB

Facebook

$139.59

1.08 (0.78%)

, YELP

Yelp

$33.50

-0.12 (-0.36%)

19:30
03/22/17
03/22
19:30
03/22/17
19:30
Periodicals
Facebook tests enhanced local search feature, TechCrunch says »

Facebook (FB) is testing…

FB

Facebook

$139.59

1.08 (0.78%)

YELP

Yelp

$33.50

-0.12 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 05

    Jun

  • 08

    Jun

ZTCOY

ZTE Corp.

$3.77

0.05 (1.34%)

19:16
03/22/17
03/22
19:16
03/22/17
19:16
Hot Stocks
DOJ says ZTE Corp pleads guilty in Iran sanctions case »

The Justice Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$110.99

0.09 (0.08%)

19:12
03/22/17
03/22
19:12
03/22/17
19:12
Hot Stocks
Avtec says signs agreement with Harris on resale of dispatch consoles »

Avtec, a provider of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$7.98

-1.12 (-12.31%)

18:59
03/22/17
03/22
18:59
03/22/17
18:59
Periodicals
Sears suppliers taking 'defensive measures,' Reuters says »

Sears' suppliers are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$75.76

-0.22 (-0.29%)

18:33
03/22/17
03/22
18:33
03/22/17
18:33
Periodicals
German prosecutors investigate Daimler employees, Bloomberg says »

Daimler AG employees are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$30.42

0.33 (1.10%)

, FOXA

21st Century Fox

$30.97

0.41 (1.34%)

18:31
03/22/17
03/22
18:31
03/22/17
18:31
Periodicals
Studios continue negotiations on accelerated release windows, Variety says »

Six of the seven largest…

FOX

21st Century Fox

$30.42

0.33 (1.10%)

FOXA

21st Century Fox

$30.97

0.41 (1.34%)

TWX

Time Warner

$96.84

-0.63 (-0.65%)

LGF.A

Lionsgate

$24.98

0.5 (2.04%)

LGF.B

Lionsgate

$23.20

0.22 (0.96%)

VIA

Viacom

$44.20

0.45 (1.03%)

VIAB

Viacom

$42.57

0.47 (1.12%)

SNE

Sony

$31.98

0.22 (0.69%)

AMC

AMC Entertainment

$30.30

0.15 (0.50%)

RGC

Regal Entertainment

$21.90

-0.21 (-0.95%)

DIS

Disney

$112.08

0.33 (0.30%)

CMCSA

Comcast

$37.04

-0.03 (-0.08%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 28

    Mar

  • 29

    Mar

  • 03

    May

  • 04

    May

  • 25

    May

JRJR

JRjr33

$0.47

-0.01 (-2.08%)

18:05
03/22/17
03/22
18:05
03/22/17
18:05
Hot Stocks
JRjr33's plan to regain listing compliancy approved by NYSE »

JRjr33 has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$829.59

-0.87 (-0.10%)

, GOOGL

Alphabet Class A

$849.80

-0.34 (-0.04%)

18:04
03/22/17
03/22
18:04
03/22/17
18:04
Hot Stocks
Google expands 'Posts on Google' test »

Google announced in a…

GOOG

Alphabet

$829.59

-0.87 (-0.10%)

GOOGL

Alphabet Class A

$849.80

-0.34 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 02

    May

  • 22

    May

CE

Celanese

$90.14

0.68 (0.76%)

18:02
03/22/17
03/22
18:02
03/22/17
18:02
Hot Stocks
Celanese increases price of vinyl acetate monomer in Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$139.59

1.08 (0.78%)

17:51
03/22/17
03/22
17:51
03/22/17
17:51
Hot Stocks
Facebook rolls out 'header bidding' ad technology »

Facebook issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

FIVE

Five Below

$38.13

-0.72 (-1.85%)

, PVH

PVH Corp.

$90.85

-1.83 (-1.97%)

17:45
03/22/17
03/22
17:45
03/22/17
17:45
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Five…

FIVE

Five Below

$38.13

-0.72 (-1.85%)

PVH

PVH Corp.

$90.85

-1.83 (-1.97%)

BEBE

bebe stores

$3.86

0.29 (8.12%)

HTGM

HTG Molecular

$2.14

0.17 (8.63%)

HTBX

Heat Biologics

$1.03

0.04 (4.04%)

RARE

Ultragenyx

$78.36

0.64 (0.82%)

GPOR

Gulfport Energy

$16.10

-0.33 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 23

    Mar

  • 23

    Mar

  • 01

    Apr

  • 06

    Jun

  • 20

    Jun

FNV

Franco-Nevada

$64.21

-1.33 (-2.03%)

17:36
03/22/17
03/22
17:36
03/22/17
17:36
Hot Stocks
Franco-Nevada sees 2021 oil and gas revenues of $55M-$65M »

Franco-Nevada expects its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

MSFT

Microsoft

$65.03

0.82 (1.28%)

17:35
03/22/17
03/22
17:35
03/22/17
17:35
Hot Stocks
LinkedIn introduces 'Trending Storylines' »

Microsoft's LinkedIn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 09

    May

FNV

Franco-Nevada

$64.21

-1.33 (-2.03%)

17:35
03/22/17
03/22
17:35
03/22/17
17:35
Hot Stocks
Franco-Nevada sees 2017 revenue from oil & gas assets of $35M-$45M »

Franco-Nevada expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

CPB

Campbell Soup

$56.91

-0.18 (-0.32%)

17:34
03/22/17
03/22
17:34
03/22/17
17:34
Hot Stocks
Campbell Soup announces $1.5B share repurchase plan »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEO

Telecom Argentina

$22.26

-0.24 (-1.07%)

17:33
03/22/17
03/22
17:33
03/22/17
17:33
Syndicate
Breaking Syndicate news story on Telecom Argentina »

Telecom Argentina files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNV

Franco-Nevada

$64.21

-1.33 (-2.03%)

17:31
03/22/17
03/22
17:31
03/22/17
17:31
Earnings
Franco-Nevada reports Q4 adjusted EPS 24c, consensus 21c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

MYL

Mylan

$41.70

0.03 (0.07%)

17:26
03/22/17
03/22
17:26
03/22/17
17:26
Periodicals
Mylan recalls 81K EpiPens outside U.S., Reuters reports »

After reports of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 03

    Sep

  • 09

    Oct

CG

Carlyle Group

$15.80

0.05 (0.32%)

17:25
03/22/17
03/22
17:25
03/22/17
17:25
Conference/Events
CFA Society of Washington, D.C. to hold a dinner »

The CFA Society of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

PENN

Penn National

$15.39

-0.28 (-1.79%)

, CYNO

Cynosure

17:19
03/22/17
03/22
17:19
03/22/17
17:19
Hot Stocks
Penn National to replace Cynosure in S&P 600 at open on March 27 »

S&P 500 constituent…

PENN

Penn National

$15.39

-0.28 (-1.79%)

CYNO

Cynosure

HOLX

Hologic

$42.09

0.15 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 29

    Mar

  • 31

    Mar

  • 06

    Jun

FIVE

Five Below

$38.13

-0.72 (-1.85%)

17:16
03/22/17
03/22
17:16
03/22/17
17:16
Recommendations
Five Below analyst commentary at Loop Capital »

Five Below Q4 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 20

    Jun

ENPH

Enphase Energy

$1.24

-0.01 (-0.80%)

17:09
03/22/17
03/22
17:09
03/22/17
17:09
Syndicate
Breaking Syndicate news story on Enphase Energy »

Enphase Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.